Clinical Trial Update: Persistent Pleural Effusion Treatment Following Cardiothoracic Surgery by Platelet-Fibrin Glue [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the use of platelet-fibrin glue to treat persistent pleural effusion after cardiothoracic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Effusion

Drugs mentioned

• Platelet-Fibrin Glue (platelet-fibrin glue)

Snippet

Sponsor: Daryoush Hamidi Alamdari, PhD | Conditions: Pleural Effusion | Phase 2 | Status: COMPLETED